0

    544445

    APL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Asston Pharmaceuticals Limited Share Price Today

    Investment Returns

    Over 1 Month -18.04% Over 3 Months -15.25% Over 6 Months -19.80% Over 1 Year -45.58%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Asston Pharmaceuticals Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 57.20
    • P/E Ratio (TTM) 14.80
    • Beta 0.28
    • Book Value / share 45.65
    • Return on equity 42.28%
    • EPS (TTM) 4.54
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    Asston Pharmaceuticals Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 25.47
    Operating Expense 26.99
    Net Profit 3.87
    Net Profit Margin (%) 15.19
    Earnings Per Share (EPS) 4.92
    EBITDA 5.54
    Effective Tax Rate (%) 15.90
    Particulars MAR 2025 (Values in Cr)
    Revenue 25.04
    Operating Expense 20.59
    Net Profit 3.85
    Net Profit Margin (%) 15.37
    Earnings Per Share (EPS) 6.14
    EBITDA 6.01
    Effective Tax Rate (%) 23.10
    Particulars MAR 2024 (Values in Cr)
    Revenue 15.59
    Operating Expense 14.02
    Net Profit 1.36
    Net Profit Margin (%) 8.72
    Earnings Per Share (EPS) 17.35
    EBITDA 2.80
    Effective Tax Rate (%) 25.27
    Particulars MAR 2023 (Values in Cr)
    Revenue 6.54
    Operating Expense 5.77
    Net Profit 1.06
    Net Profit Margin (%) 16.20
    Earnings Per Share (EPS) 15.09
    EBITDA 2.17
    Effective Tax Rate (%) 25.53
    Particulars MAR 2022 (Values in Cr)
    Revenue 9.60
    Operating Expense 10.39
    Net Profit 0.11
    Net Profit Margin (%) 1.14
    Earnings Per Share (EPS) 1.58
    EBITDA 0.60
    Effective Tax Rate (%) 31.25
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 17.60
    ROE % 42.28
    ROCE % 36.73
    Total Debt to Total Equity 0.77
    EBITDA Margin 24.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 91.63
    ROE % 53.00
    ROCE % 37.65
    Total Debt to Total Equity 1.32
    EBITDA Margin 25.39
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 28.37
    ROE % 72.60
    ROCE % 36.93
    Total Debt to Total Equity 2.93
    EBITDA Margin 33.18
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 13.28
    ROE % 11.83
    ROCE % 13.75
    Total Debt to Total Equity 3.56
    EBITDA Margin 6.25
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.19
    Total Assets 28.12
    Total Liabilities 28.12
    Total Equity 11.03
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 13.69
    Return on Capital (%) 21.06
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 20.26
    Total Liabilities 20.26
    Total Equity 6.39
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.71
    Return on Capital (%) 10.3
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 13.69
    Total Liabilities 13.69
    Total Equity 1.98
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 7.71
    Return on Capital (%) 14.61
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.13
    Total Assets 9.49
    Total Liabilities 9.49
    Total Equity 0.92
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.16
    Return on Capital (%) 2.61
    Particulars MAR 2025 (Values in Cr)
    Net Income 5.01
    Cash from Operations 0.00
    Cash from Investing 0.73
    Cash from Financing -0.51
    Net change in Cash 0.19
    Free Cash Flow 0.01
    Particulars MAR 2024 (Values in Cr)
    Net Income 3.25
    Cash from Operations -3.51
    Cash from Investing 0.00
    Cash from Financing 3.85
    Net change in Cash -0.11
    Free Cash Flow -3.50
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.41
    Cash from Operations -0.30
    Cash from Investing -0.91
    Cash from Financing 1.21
    Net change in Cash -0.01
    Free Cash Flow -0.05
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.15
    Cash from Operations -1.15
    Cash from Investing 0.00
    Cash from Financing 1.29
    Net change in Cash 0.10
    Free Cash Flow -1.15
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMA LT 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD 482.50 52.16 4.42 5117.21 118.35 552.90

    Asston Pharmaceuticals Limited shareholding pattern

    Holding
    47.42%
    50.66%
    1.91%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Asston Pharmaceuticals Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    67.20 -8.57 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 72.40
    • 26 Days 75.90
    • 10 Days 74.20
    • 50 Days 76.90
    • 12 Days 74.60
    • 100 Days 79.70
    • 20 Days 75.50
    • 200 Days 87.30
    73.33 PIVOT
    First Support 73.17 First Resistance 73.67 Second Support 72.83 Second Resistance 73.83 Third Support 72.67 Third Resistance 74.17
    RSI 34.37 ADX 32.42 MACD -1.28 Williams % R -86.27 Commodity Channel Index (CCI) -180.75
    Date 2026-07-17 Week 30750.00 Same Day 114000.00 Month 12800.00
    1 Year 0.29 3 Year 0.31
    Over 1 Month
    -18.04% down
    Over 1 Year
    -45.58% down
    Over 3 Months
    -15.25% down
    Over 3 Years
    0.00% down
    Over 6 Months
    -19.80% down
    Over 5 Years
    0.00% down

    Asston Pharmaceuticals Limited Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Asston Pharmaceuticals Ltd?

    Answer Field

    Asston Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 67.20 as on Jul 17 2026 03:13 PM.

    What is the Market Cap of Asston Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Asston Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 57.20 as on Jul 17 2026 03:13 PM.

    What is the 52 Week High and Low of Asston Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Asston Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 126.00 and ₹ 61.02.

    What is 1 year return for Asston Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -45.58%.

    What is the P/E Ratio of Asston Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 17 2026 03:13 PM the price-to-earnings (PE) ratio for Asston Pharmaceuticals Ltd share is 14.80.

    What is the PB ratio of Asston Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 17 2026 03:13 PM, the price-to-book (PB) ratio for Asston Pharmaceuticals Ltd share is 45.65.

    How to Buy Asston Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Asston Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Asston Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Asston Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Asston Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |